VIDEO: Avoidable Costs in U.S. Healthcare

Sep 6, 2013

Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."

Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."

Accelerated Brain Aging Found in Patients with T1D, but Unrelated to Alzheimer's

June 1st 2023

Accelerated Brain Aging Found in Patients with T1D, but Unrelated to Alzheimer's

June 1st 2023

Episode 6: High Risk: Diabetes and COVID-19

July 24th 2020

The Importance of Health Equity in Diabetes Care

May 15th 2023

CGM Technology Has a Role Outside of Diabetes Care

May 15th 2023

FDA Clears Wearable Insulin Delivery Device Omnipod GO for Type-2 Diabetes

April 27th 2023

FDA Approval: Medtronic MiniMed 780G Insulin Pump System for T1D

April 25th 2023

Accelerated Brain Aging Found in Patients with T1D, but Unrelated to Alzheimer's

June 1st 2023

Episode 6: High Risk: Diabetes and COVID-19

July 24th 2020

The Importance of Health Equity in Diabetes Care

May 15th 2023

CGM Technology Has a Role Outside of Diabetes Care

May 15th 2023

FDA Clears Wearable Insulin Delivery Device Omnipod GO for Type-2 Diabetes

April 27th 2023

FDA Approval: Medtronic MiniMed 780G Insulin Pump System for T1D

April 25th 2023

Related Content

Accelerated Brain Aging Found in Patients with T1D, but Unrelated to Alzheimer's

June 1st 2023

Article

Individuals with type 1 diabetes (T1D) had brain atrophy patterns equivalent to a brain age about 6 years older than their actual age.

Over the Counter, the podcast from Drug Topics

Episode 6: High Risk: Diabetes and COVID-19

July 24th 2020

Podcast

In this episode of Over the Counter, 2 experts on diabetes management and care discuss the effect COVID-19 is having on individuals with diabetes and the ways that the health care system is responding.